REQUEST A DEMO
Total
USD $0.00
Search more companies

Stilbene Biopharma Private Limited (India)

Main Activities: Heavy and Civil Engineering Construction
Full name: Stilbene Biopharma Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Stilbene Biopharma Private Limited is an unlisted company, incorporated on 22/06/2005. It has its registered office in the State of Andhra Pradesh LLP, India. Company's corporate identification number (CIN) is U45200AP2005PTC046614 and registration number is 046614. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
1/232. Maredubaka Nearmandapeta . Mandapeta .
East Godavari; Andhra Pradesh; Postal Code: 533308

Contact Details: Purchase the Stilbene Biopharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Stilbene Biopharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Stilbene Biopharma Private Limited report to view the information.
Registered Capital:
Purchase the Stilbene Biopharma Private Limited report to view the information.
Incorporation Date:
June 22, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Stilbene Biopharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
5.75%
Total operating revenue
5.79%
Operating profit (EBIT)
34.33%
EBITDA
28.14%
Net Profit (Loss) for the Period
36.15%
Total assets
11.12%
Total equity
36.51%
Operating Profit Margin (ROS)
7.13%
Net Profit Margin
5.6%
Return on Equity (ROE)
-0.07%
Debt to Equity Ratio
-25.9%
Quick Ratio
0.38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?